Cambridge Advisors Inc. continued to hold its position in Monsanto Company (NYSE:MON) during the second quarter, Holdings Channel reports. The fund owned 2,675 shares of the basic materials company’s stock at the end of the second quarter. Cambridge Advisors Inc.’s holdings in Monsanto were worth $317,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of MON. BlackRock Inc. boosted its position in Monsanto by 2,390.1% in the first quarter. BlackRock Inc. now owns 26,192,816 shares of the basic materials company’s stock valued at $2,965,029,000 after buying an additional 25,140,936 shares in the last quarter. State Street Corp boosted its position in Monsanto by 1.2% in the first quarter. State Street Corp now owns 20,153,966 shares of the basic materials company’s stock valued at $2,281,433,000 after buying an additional 234,582 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its position in Monsanto by 3.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 14,299,502 shares of the basic materials company’s stock valued at $1,618,703,000 after buying an additional 499,639 shares in the last quarter. Geode Capital Management LLC boosted its position in Monsanto by 7.7% in the first quarter. Geode Capital Management LLC now owns 4,125,879 shares of the basic materials company’s stock valued at $466,359,000 after buying an additional 295,452 shares in the last quarter. Finally, Flossbach Von Storch AG boosted its position in Monsanto by 33.9% in the first quarter. Flossbach Von Storch AG now owns 4,089,400 shares of the basic materials company’s stock valued at $462,920,000 after buying an additional 1,034,400 shares in the last quarter. 75.31% of the stock is owned by hedge funds and other institutional investors.

Shares of Monsanto Company (NYSE MON) traded down 0.3746% during trading on Wednesday, hitting $116.8208. The stock had a trading volume of 907,145 shares. The company has a market capitalization of $51.32 billion, a price-to-earnings ratio of 25.2313 and a beta of 1.07. The company’s 50 day moving average price is $117.53 and its 200 day moving average price is $114.77. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97.

Monsanto (NYSE:MON) last posted its quarterly earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. The company had revenue of $4.23 billion for the quarter, compared to analysts’ expectations of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. Monsanto’s revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.17 EPS. Analysts predict that Monsanto Company will post $4.89 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Friday, July 7th were issued a $0.54 dividend. The ex-dividend date of this dividend was Wednesday, July 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.84%. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.

ILLEGAL ACTIVITY WARNING: This piece was reported by Daily Political and is owned by of Daily Political. If you are reading this piece on another publication, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/09/monsanto-company-mon-stake-held-by-cambridge-advisors-inc.html.

Several research firms recently issued reports on MON. Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 target price on the stock in a report on Thursday, July 6th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 target price on the stock in a report on Friday, June 16th. Barclays PLC upped their target price on Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a report on Thursday, June 29th. BidaskClub upgraded Monsanto from a “sell” rating to a “hold” rating in a report on Thursday, June 29th. Finally, Jefferies Group LLC lowered Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price on the stock. in a report on Wednesday, July 12th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and eight have given a buy rating to the company. The company has an average rating of “Hold” and a consensus price target of $123.15.

In related news, EVP Robert T. Fraley sold 52,410 shares of Monsanto stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $117.95, for a total value of $6,181,759.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Steven Mizell sold 11,300 shares of Monsanto stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the sale, the executive vice president now directly owns 55,011 shares in the company, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. Insiders sold a total of 74,470 shares of company stock worth $8,791,281 in the last ninety days. 0.79% of the stock is currently owned by insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.